Immunome Inc (IMNM)

Stock-Based Compensation

$8.80M

Quarterly · Period ending: · USD

IMNM logo

IMNM Stock-Based Compensation

Latest reported$8.80M
IMNM Quarterly Stock-Based Comp ($5.00K → $8.80M)
High-resolution chart · PNG

IMNM stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
8,799,000
7,953,000
7,893,000
6,747,000
5,347,000
5,703,000
5,470,000
4,892,000
3,227,000
2,159,000
2,883,000
1,083,000
1,033,000
1,224,000
1,355,000
1,340,000
1,327,000
1,310,000
1,219,000
1,155,000
749,000
325,000
319,000
117,000
39,000
146,000
3,000
1,000
5,000
5,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.